Supplementary Table 2 from The PI3K/mTOR Inhibitor Ompalisib Suppresses Nonhomologous End Joining and Sensitizes Cancer Cells to Radio- and Chemotherapy
posted on 2023-04-03, 19:45authored byJie Du, Fuqiang Chen, Jiahua Yu, Lijun Jiang, Meijuan Zhou
Table S2. Full table of the screening results.
Funding
National Natural Science Foundation of China
China Postdoctoral Science Foundation
History
ARTICLE ABSTRACT
In summary, our findings suggested the possibility for repurposing these candidates as radio- or chemosensitizers, which might extend their clinical application in cancer therapy.